News & Updates
Filter by Specialty:
Early molnupiravir use benefits unvaccinated COVID-19 outpatients
Early administration (ie, within 5 days after symptom onset) of the oral, small-molecule antiviral prodrug molnupiravir slashed the risk of hospitalization or death in at-risk, unvaccinated, nonhospitalized adults with mild-to-moderate COVID-19, findings from the phase III component of the phase II/III MOVe-OUT trial have shown.
Early molnupiravir use benefits unvaccinated COVID-19 outpatients
18 Apr 2022
Vitamin E supplementation improves metabolic, hormonal profile in women with PCOS
Regimens containing vitamin E supplements might help improve blood lipid profile and glucose control in women with polycystic ovary syndrome (PCOS), reports a recent meta-analysis.
Vitamin E supplementation improves metabolic, hormonal profile in women with PCOS
17 Apr 2022
High-intensity training eases anxiety, stress in prostate cancer
A supervised high-intensity interval training (HIIT) program for 12 weeks leads to improvements in prostate cancer-specific anxiety, fear of cancer progression, hormone symptoms, stress, fatigue, and self-esteem in men on active surveillance, reports a study.
High-intensity training eases anxiety, stress in prostate cancer
17 Apr 2022
Noninvasive nerve stimulation device eases migraine
External trigeminal nerve stimulation (e-TNS) helps relieve pain and reduce other symptoms associated with migraine, according to a recent study. E-TNS presents a safe, effective, noninvasive, and nonpharmacological intervention for migraine.
